Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities

Experimental Cell Research

Volumn 240, Issue 1, 1998, Pages 107-121

  Schmitt, E ^a   Cimoli, G ^a   Steyaert, A ^a   Bertrand, R ^a  

^a Institut du Cancer de Montreal   (Canada)

Author keywords

Apoptosis; Bcl xL; Cancer chemotherapy; Caspases; N tosyl L phenylalanylchloromethyl ketone

Indexed keywords

ALDEHYDE; ANTINEOPLASTIC AGENT; ASPARTYLGLUTAMYLVALYLASPARTIC ACID ALDEHYDE; CAMPTOTHECIN; CISPLATIN; CYSTEINE PROTEINASE; DNA FRAGMENT; DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE; GENE PRODUCT; PACLITAXEL; PROTEIN BCL 2; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; UNCLASSIFIED DRUG; VINBLASTINE;

APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA STRAND BREAKAGE; DNA SYNTHESIS INHIBITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EUKARYOTA;

EID: 0031843863     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4003     Document Type: Article

References (134)

1. Wyllie, A. H. (1987). Apoptosis: cell death in tissue regulation. J. Pathol. 153, 313-316.
2. Ellis, R. E., Yuan, J., and Horvitz, H. R. (1991). Mechanisms and functions of cell death. Annu. Rev. Cell. Biol. 7, 663-698.
3. Wyllie, A. H. (1992). Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev. 11, 95-103.
4. Thompson, C. (1995). Apoptosis in the Pathogenesis and treatment of disease. Science 267, 1456-1462.
5. Kerr, J. F., Wyllie, A. H., and Currie, A. R. (1972). Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26, 239-257.
6. Wyllie, A. H., Morris, R. G., Smith, A. L., and Dunlop, D. (1984). Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis. J. Pathol. 142, 67-77.
7. Kerr, J. F., Gobe, G. C., Winterford, C. M., and Harmon, B. V. (1995). Anatomical methods in cell death. Methods Cell Biol. 46, 1-27.
8. Hengartner, M. O., Ellis, R. E., and Horvitz, H. R. (1992). Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 356, 494-496.
9. Yuan, J., Shaham, S., Ledoux, S., Ellis, H. M., Horvitz, R. (1993). The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukine-1B-converting enzyme. Cell 75, 641-652.
10. Hengartner, M. O., and Horvitz, H. R. (1994). Programmed cell death in Caenorhabditis elegans. Current Opin. Genet. Dev. 4, 581-6.
11. Hengartner, M. O., and Horvitz, H. R. (1994). C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76, 665-76.
12. Horvitz, H. R., Shaham, S., and Hengartner, M. O. (1994). The genetics of programmed cell death in the nematode Caenorhabditis elegans. Cold Spring Harb. Symp. Quant. Biol. 59, 377-385.
13. Vaux, D. L., Cory, S., and Adaams, J. M. (1988). Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 355, 440-442.
14. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R. D., and Korsmeyer, S. J. (1990). Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348, 334-336.
15. Korsmeyer, S. J. (1992). Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80, 879-886.
16. Reed, J. C. (1994). Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124, 1-6.
17. Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S. J. (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-19.
18. Boise, L. H., Gonzalez-Garcia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G., and Thompson, C. B. (1993). Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597-608.
19. Kozopas, K. M., Yang, T., Buchan, H. L., Zhou, P., and Craig, R. W. (1993). MCL1 a gene expressed in programmed myeloid cell differentiation, has sequence similarity to Bcl-2. Proc. Natl. Acad. Sci. USA 90, 3516-3520.
20. Lin, E. Y., Orlofsky, A., Berger, M. S., and Prystowsky, M. B. (1993). Characterization of A1, a nvel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J. Immunol. 151, 1979-1988.
21. Farrow, S. N., White, J. H., Martinou, I., Raven, T., Pun, K. T., Grinham, C. J., Martinou, J. C., and Brown, R. (1995). Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K Nature 374, 731-3.
22. Chittenden, T., Harrington, E. A., O'Connor, R., Flemington, C., Lutz, R. J., Evan, G. I., and Guild, B. C. (1995). Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374, 733-6.
23. Kiefer, M. C., Brauer, M. J., Powers, V. C., Wu, J. J., Umansky, S. R., Tomei, L. D., and Barr, P. J. (1995). Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374, 736-9.
24. Yang, E., Zha, J., Jockel, J., Boise, L. H., Thompson, C. B., and Korsmeyer, S. J. (1995). Bad, a heterodimeric partner for Bel-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80, 285-91.
25. Choi, S. S., Park, I. C., Yun, J. W., Sung, Y. C., Hong, S. I., and Shin, H. S. (1995). A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene 11, 1693-1698.
26. Boyd, J. M., Gallo, G. J., Elangovan, B., Houghton, A. B., Malstrom, S., Avery, B. J., Ebb, R. G., Subramanian, T., Chittenden, T., Lutz, R. J., and Chinnadurai, G. (1995). Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11, 1921-1928.
27. Gibson, L., Holmgreen, S. P., Huang, D. C. S., Bernand, O., Copeland, N. G., Jenkins, N. A., Sutherland, G. R., Baker, E., Adams, J. M., and Cory, S. (1996). Bcl-W, a novel member of the Bcl-2 family, promotes cell survival. Oncogene 13, 665-675.
28. Das, R., Reddy, E. P., Chatterjee, D., and Andrews, D. W. (1996). Identification of a novel Bcl-2 related gene, Brag-1, in human glioma. Oncogene 12, 947-951.
29. Wang, K., Yin, X. M., Chao, D. T., Milliman, C. L., and Korsmeyer, S. J. (1996). Bid - A novel Bh3 domain-only death agonist. Genes Dev. 10, 2859-2869.
30. Inohara, N., Ding, L. Y., Chen, S., and Nunez, G. (1997). Harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X-L. EMBO J. 16, 1686-1694.
31. Tsujiimoto, Y., Finger, L. R., Yunis, J., Nowell, P. C., and Croce, C. M. (1984). Cloning of the chromosome breakpoint of neoplastic B cells with the t(14:18) chromosome translocation. Science 226, 1097-1099.
32. Clarke, M. L., Smith, S. D., and Sklar, J. (1986). Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14; 18) translocation. Cell 47, 19-28.
33. Korsmeyer, S. J. (1993). Programmed cell death: Bcl-2. Important Adv. Oncol. 19-28.
34. Reed, J. C. (1994). Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124, 1-6.
35. Reed, J. C. (1995). Bcl-2: Prevention of apoptosis as a mechanism of drug resistance. Hematol. Oncol. Clin. North Am. 9, 451-73.
36. Reed, J. C. (1995). Bcl-2 Family Proteins - Regulators Of Chemoresistance In Cancer. Toxicol. Letts. 3, 155-158.
37. Korsmeyer, S. J. (1995). Regulators of cell death.Trends Genet. 11, 101-5.
38. Hockenbery, D. M. (1995). Bcl-2, a novel regulator of cell death. Bioessays 17, 631-8.
39. Datta, R., Manome, Y., Taneja, N., Boise, L., Weichselbaum, R., Thompson, C., and Kufe, D. (1995). Overexpression of Bcl-xL by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation. Cell Growth Differ 6, 363-370.
40. Dole, M. G., Jasty, R., Cooper, M. J., Thompson, C. B., Nunez, G., and Castle, V. P. (1995). Bcl-X(L) is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res. 55, 2576-2582.
41. Fang, W., Rivard, J. J., Ganser, J. A., LeBien, T. W., Nath, K. A., Mueller, D. L., and Behrens, T. W. (1995). Bcl-xL rescues WEHI 231 B lymphocytes from oxidant-mediated death following diverse apoptotic stimuli. J Immunol. 155, 66-75.
42. Ibrado, A. M., Huang, Y., Fang, G. F., and Bhalla, K. (1996). Bcl-X(L) Overexpression inhibits taxol-induced yama protease activity and apoptosis. Cell Growth Differ. 7, 1087-1094.
43. Krajewski, S., Blomqvist, C., Franssila, K., Krajewska, M., Wasenius, V. M., Niskanen, E., Nordling, S., and Reed, J. C. (1995). Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res. 55, 4471-8.
44. Thomas, A., Elrouby, S., Reed, J. C., Krajewski, S., Silber, R., Potmesil, M., and Newcomb, E. W. (1996). Drug-induced apoptosis in b-cell chronic lymphocytic leukemia-Relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Oncogene 12, 1055-1062.
45. Chresta, C. M., Masters, J. R. W., and Hickman, J. A. (1996). Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional P53 and a high Bax-Bcl-2 ratio. Cancer Res. 56, 1834-1841.
46. Sakakura, C., Sweeney, E. A., Shirahama, T., Igarashi, Y., Hakomori, S., Nakatani, H., Tsujimoto, H., Imanishi, T., Ohgaki, M., Ohyama, T., Yamazaki, J., Hagiwara, A., Yamaguchi, T., Sawai, K., and Takahashi, T. (1996). Overexpression of bax sensitizes human breast cancer Mcf-7 cells to radiation-induced apoptosis. Int. J. Cancer 67, 101-105.
47. Wagener, C., Bargou, R. C., Daniel, P. T., Bommert, K., Mapara, M. Y., Royer, H. D., and Dorken, B. (1996). Induction of the death-promoting gene Bax-Alpha sensitizes cultured breast-cancer cells to drug-induced apoptosis. Int. J. of Cancer 67, 138-141.
48. Sumantran, V. N., Ealovega, M. W., Nunez, G., Clarke, M. F., and Wicha, M. S. (1995). Overexpression Of Bcl-X(S), Sensitizes Mcf-7 cells to chemotherapy-induced apoptosis. Cancer Res. 55, 2507-2510.
49. Ealovega, M. W., McGinnis, P. K., Sumantran, V. N., Clarke, M. F., and Wicha, M. S. (1996). Bcl-X(S) gene therapy induces apoptosis of human mammary tumors in nude mice. Cancer Res. 56, 1965-1969.
50. Alnemri, E. S., Fernandes-Alnemri, T., and Litwack, G. (1995). Cloning and expression of four novel isoforms of human interleukin-1 beta converting enzyme with different apoptotic activities. J. Biol. Chem. 270, 4312-7.
51. Kamens, J., Paskind, M., Hugunin, M., Talanian, R. V., Allen, H., Banach, D., Bump, N., Hackett, M., Johnston, C. G., Li, P., Mankovich, J. A., Terranova, M., and Ghayur, T. (1995). Identification and characterization of Ich-2, a novel member of the interleukin-1-beta-converting enzyme family of cysteine proteases. J. Biol.Chem. 270, 15250-15256.
52. Faucheu, C., Diu, A., Chan, A. W., Blanchet, A. M., Miossec, C., Herve, F., Collard-Dutilleul, V., Gu, Y., Aldape, R. A., Lippke, J. A., and et al. (1995). A novel human protease similar to the interleukin-1 beta converting enzyme induces apoptosis in transfected cells. EMBO J. 14, 1914-22.
53. Munday, N. A., Vaillancourt, J. P., Ali, A., Casano, F. J., Miller, D. K., Molineaux, S. M., Yamin, T. T., Yu, V. L., and Nicholson, D. W. (1995). Molecular cloning and pro-apoptotic activity of ICErelII and ICErelIII, members of the ICE/CED-3 family of cysteine proteases. J. Biol. Chem. 270, 15870-6.
54. Faucheu, C., Blanchet, A. M., Collarddutilleul, V., Lalanne, J. L., and Diuhercend, A. (1996). Identification Of a Cysteine Protease Closely Related to Interleukin-1-Beta-Converting Enzyme. Eur.J. Biochem. 236, 207-213.
55. Wang, S. Y., Miura, M., Jung, Y. K., Zhu, H., Gagliardini, V., Shi, L. F., Greenberg, A. H., and Yuan, J. Y. (1996). Identification and characterization of Ich-3, a member of the interleukin-1-beta converting enzyme (ice)/ced-3 family and an upstream regulator of ice. J. Biol.Chem. 271, 20580-20587.
56. Fernandes-Alnemri, T., Litwack G, and ES, A. (1994). CPP32 a novel apoptotic protein with homology to C.elegans cell death protein Ced-3 and mammalian IL-1 converting enzyme. J Biol. Chem 269, 30761-30764.
57. Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S., and Dixit, V. M. (1995). Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81, 801-9.
58. Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., and et al. (1995). Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376, 37-43.
59. Fernandes-Alnemri, T., Litwack, G., and Alnemri, E. S. (1995). Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. Cancer Res. 55, 2737-42.
60. Fernandes-Alnemri, T., Takahashi, A., Armstrong, R., Krebs, J., Fritz, L., Tomaselli, K. J., Wang, L., Yu, Z., Croce, C. M., Salveson, G., Earnshaw, W. C., Litwack, G., and Alnemri, E. S. (1995). Mch3, a novel human apoptotic cysteine protease highly related to Cpp32. Cancer Res. 55, 6045-6052.
61. Duan, H. J., Chinnaiyan, A. M., Hudson, P. L., Wing, J. P., He, W. W., and Dixit, V. M. (1996). Ice-Lap3, a novel mammalian homologue of the caenorhabditis elegans cell death protein Ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosis. J. Biol.Chem. 271, 1621-1625.
62. Lippke, J. A., Gu, Y., Sarnecki, C., Caron, P. R., and Su, M. S. S. (1996). Identification and characterization of Cpp32/ 2mch2 homolog 1, a novel cysteine protease similar to Cpp32. J. Biol. Chem. 271, 1825-1828.
63. Fernandes-Alnemri, T., Amstrong, R. C., Krebs, J., Srinivasula, S. M., Wang, L., Bullrich, F., Fritz, L. C., Trapani, J. A., Tomaselli, K. J., Litwack, G., and Alnemri, E. S. (1996). In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FDD-like domains. Proc. Natl. Acad. Sci. USA 93, 7464-7469.
64. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., Orourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer, P. H., Peter, M. E., and Dixit, V. M. (1996). Flice, a novel Fadd-homologous Ice/Ced-3-like protease, is recruited to the Cd95 (Fas/Apo-1) death-inducing signaling complex. Cell 85, 817-827.
65. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V., and Wallach, D. (1996). Involvement of Mach, a novel Mortl/Fadd-interacting protease, in Fas/Apo-1- and Tnf receptor-induced cell death. Cell 85, 803-815.
66. Wang, L., Miura, M., Bergeron, L., Zhu, H., and Yuan, J. (1994). Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78, 739-50.
67. Duan, H. J., Orth, K., Chinnaiyan, A. M., Poirier, G. G., Froelich, C. J., He, W. W., and Dixit, V. M. (1996). Ice-Lap6, a novel member of the Ice/Ced-3 gene family, is activated by the cytotoxic T cell protease Granzyme B. J. Biol. Chem. 271, 16720-16724.
68. Heusel, J. W., Wesselschmidt, R. L., Shresta, S., Russell, J. H., and Ley, T. J. (1994). Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76, 977-87.
69. Greenberg, A. H., and Litchfield, D. W. (1995). Granzymes and apoptosis: Targeting the cell cycle. Current Topics Microbiol. Immunol. 198, 95-119.
70. Wright, S. C., Wei, Q. S., Zhong, J., Zheng, H., Kinder, D. H., and Larrick, J. W. (1994). Purification of a 24-kD protease from apoptotic tumor cells that activates DNA fragmentation. J Exp. Med. 180, 2113-23.
71. Marthinuss, J., Andradegordon, P., and Seiberg, M. (1995). A secreted serine protease can induce apoptosis in Pam212 keratinocytes. Cell Growth & Differ. 6, 807-816.
72. Schlegel, J., Peters, I., and Orrenius, S. (1995). Isolation and partial characterization of a protease involved in Fas-induced apoptosis. FEBS Lett. 364, 139-42.
73. Bruno, S., DelBino, G., Lassota, P., Giaretti, W., and Darynkiewicz, Z. (1992). Inhibitors of proteases prevent endonucleolysis accompanying apoptotic death of HL60 leukemic cells and normal thymocytes. Leukemia 6, 1113-1120.
74. Weaver, V. M., Lach, B., Walker, P. R., and Sikorska, M. (1993). Role of proteolysis in apoptosis: Involvement of serine proteases in internucleosomal DNA fragmentation in immature thymocytes. Biochem. Cell Biol. 71, 488-500.
75. Ghibelli, L., Maresca, V., Coppola, S., and Gualandi, G. (1995). Protease inhibitors block apoptosis at intermediate stages - a compared analysis of dna fragmentation and apoptotic nuclear morphology. FEBS Lett. 377, 9-14.
76. Yoshida, A., Takauji, R., Inuzuka, M., Ueda, T., and Nakamura, T. (1996). Role of serine and ice-like proteases in induction of apoptosis by etoposide in human leukemia Hl-60 cells. Leukemia 10, 821-824.
77. Hara, S. S., Halicka, H. D., Bruno, S., Gong, J. P., Traganos, F., and Darzynkiewicz, Z. (1996). Effect of protease inhibitors on early events of apoptosis. Exp. Cell Res. 223, 372-384.
78. Shimizu, T., and Pommier, Y. (1996). DNA fragmentation induced by protease activation in P53-null human leukemia hl60 cells undergoing apoptosis following treatment with the topoisomerase I inhibitor camptothecin - Cell-free system studies. Exp. Cell Res. 226, 292-301.
79. Solary, E., Dubrez, L., Eymin, B., Bertrand, R., and Pommier, Y. (1996). Apoptosis induction in human leukemic cells by topoisomerase I and II inhibitors. Bulletin du Cancer 83, 205-212.
80. Sané, A. T., Schmitt, E., Steyaert, A., Meyer, D., and Bertrand, R. (1997). The CrmA- and TPCK-sensitive pathways that trigger the oligonucleosome-sized DNA fragmentation in camptothecin-induced apoptosis; relation to caspase activation and hig molecular weight DNA fragmentation. Biochemi Cell Biol. 75, 359-368.
81. Dubrez, L., Savoy, I., Hamman, A., and Solary, E. (1996). Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways. EMBO J. 15, 5504-5512.
82. Adjei, P. N., Kaufmann, S. H., Leung, W. Y., Mao, F., and Gores, G. J. (1996). Selective induction of apoptosis in Hep 3b cells by Topoisomerase I inhibitors - Evidence for a protease-dependent pathway that does not activate cysteine protease P32. J. of Clin. Invest. 98, 2588-2596.
83. Jaxel, C., Taudou, G., Portemer, C., Mirambeau, G., Panijel, J., and Duguet, M. (1988). Topoisomerase inhibitors induce irreversible fragmentation of replicated DNA in concanavalin A stimulated splenocytes. Biochem. 27, 95-99.
84. Kaufmann, S. H. (1989). Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: A cautionary note. Cancer Res. 49, 5870-5878.
85. Barry, M. A., Behnke, C. A., and Eastman, A. (1990). Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol. 40, 2353-2362.
86. Bertrand, R., Sarang, M., Jenkin, J., Kerrigan, D., and Pommier, Y. (1991). Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression. Cancer Res. 51, 6280-6285.
87. Walker, P. R., Smith, C., Youdale, T., Leblanc, J., Whitfield, J. F., and Sikorska, M. (1991). Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res. 51, 1078-1085.
88. Bertrand, R., Solary, E., Jenkins, J., and Pommier, Y. (1993). Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors. Exp.Cell Res. 207, 388-97.
89. Solary, E., Bertrand, R., Kohn, K. W., and Pommier, Y. (1993). Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood 81, 1359-68.
90. Rowe, T. C., Chen, G. L., Hsiang, Y. H., and Liu, L. F. (1986). DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II. Cancer Res. 46, 2021-2026.
91. Pommier, Y., and Kohn, K. W. (1989). Topoisomerase II inhibition by antitumor intercalators and demethylepipodophyllotoxins. In ℧Developments in Cancer Chemotherapy℧ (R. I. Gazer, Ed.), Vol. 2, pp. 175-196, CRC Press, Boca Raton, FL.
92. Liu, L. F. (1989). DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem. 58, 351-375.
93. Pommier, Y., and Tanizawa, A. (1993). Mammalian DNA topoisomerase I and its inhibitors. In ℧Cancer Chemotherapy℧ (J. Hickman and T. Tritton, Eds.), pp. 214-250, Blackwell Scientific Publications LTD, Oxford.
94. Pommier, Y., Leteurtre, F., Fesen, M. R., Fujimori, A., Bertrand, R., Solary, E., Kohlhagen, G., and Kohn, K. W. (1994). Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors. Cancer Invest. 12, 530-42. [Review]
95. Holm, C., Covey, J. M., Kerrigan, D., and Pommier, Y. (1989). Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. Cancer Res. 49, 6365-6368.
96. Hsiang, Y.-H., Lihou, M. G., and Liu, L. F. (1989). Arrest of DNA replication by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res. 49, 5077-5082.
97. D'Arpa, P., Beardmore, C., and Liu, L. F. (1990). Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. Cancer Res. 50, 6919-6924.
98. Bertrand, R., O'Connor, P., Kerrigan, D., and Pommier, Y. (1992). Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human carcinoma, HT-29 cells. Eur. J. Cancer. 28A, 743-748.
99. Hickman, J. A., Potten, C. S., Merritt, A. J., and Fisher, T. C. (1994). Apoptosis and cancer chemotherapy. Phil. Trans. R. Soc. London - Ser. B: Biol. Sci. 345, 319-25.
100. Hickman, J. A. (1996). Apoptosis and Chemotherapy Resistance. Eur. J. Cancer 32A, 921-926.
101. Wyllie, A. H. (1995). The genetic regulation of apoptosis. Curr. Opin. Genet. Dev. 5, 97-104.
102. Kumar, S., and Harvey, N. L. (1995). Role of multiple cellular proteases in the execution of programmed cell death. FEBS Lett. 375, 169-173.
103. Patel, T., Gores, G. J., and Kaufmann, S. H. (1996). The role of proteases during apoptosis. FASEB J. 10, 587-597.
104. Bertrand, R., Kohn, K., Solary, E., and Pommier, Y. (1995). Detection of apoptosis-associated DNA fragmentation using a rapid and quantitative filter elution assay. Drug Dev. Res 34, 138-144.
105. Bertrand, R., and Pommier, Y. (1995). Assessment of DNA damage in Mammalian cells by DNA filter elution methodology. In "Cell Growth and Apoptosis; A Pratical Approach" (G. P. Studzinski, Ed.), Vol. 159, pp. 97-118, IRL Press, New York.
106. Enari, M., Talanian, R. V., Wong, W. W., and Nagata, S. (1996). Sequential activation of ice-like and Cpp32-like proteases during Fas-mediated apoptosis. Nature 380, 723726.
107. Del Bino, G., and Darzynkiewicz, Z. (1991). Camptothecin, Teniposide, or 4′-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S-phase HL-60 cells. Cancer Res. 51, 1165-1169.
108. Minn, A. J., Velez, P., Schendel, S. L., Liang, H., Muchmore, S. W., Fesik, S. W., Fill, M., and Thompson, C. B. (1997). Bcl-xL forms an ion channel in synthetic lipid membranes. Nature 385, 353-357.
109. Schendel, S. L., Xie, Z. H., Montal, M. O., Matsuyama, S., Montai, M., and Reed, J. C. (1997). Channel Formation By Antiapoptotic Protein Bcl-2. Proc.Nat. Acad.Sci. USA 94, 5113-5118.
110. Antonsson, B., Conti, F., Ciavatta, A., Montessuit, S., Lewis, S., Martinou, I., Bernasconi, L., Bernard, A., Mermod, J. J., Mazzei, G., Maundrell, K., Gambale, F., Sadoul, R., and Martinou, J. C. (1997). Inhibition of Bax channel-forming activity by Bcl-2. Science 277, 370-372.
111. Bertrand, R., Solary, E., O'Connor, P., Kohn, K. W., and Pommier, Y. (1994). Induction of a common pathway of apoptosis by staurosporine. Exp. Cell Res. 211, 314-21.
112. Sané, A. T., and Bertrand, R. (1997). Distinct steps in DNA fragmentation pathway during apoptosis involved caspase, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities protease activation. Submitted.
113. Lazebnik, Y. A., Takahashi, A., Moir, R. D., Goldman, R. D., Poirier, G. G., Kaufmann, S. H., and Earnshaw, W. C. (1995). Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc. Nat. Acad. Sci. USA 92, 9042-9046.
114. Schmitt, E., Steyeart, A., and Bertrand, R. (1995). Bcl-xes, a novel bcl-x-related cDNA in human cells; potential role regulating apoptosis. In "Programmed Cell Death Meeting," Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
115. Krajewski, S., Krajewska, M., and Reed, J. C. (1994). Immunohistochemical analysis of in vivo patterns of Bcl-x expression. Cancer Res. 54, 5501-5507.
116. Gonzales-Garcia, M., Garcia, I., Ding, L., O'Shea, S., Boise, L., Thompson, C., and Numez, G. (1995). bcl-x is expressed in embryonic and postnatal neural tissues and function to prevent neuronal cell death. Proc. Natl. Acad. Sci. USA 92, 4304-4308.
117. Motoyama, N., Wang, F., Roth, K A., Sawa, H., Nakayama, K., Nakayama, K., Negishi, I., Senju, S., Zhang, Q., Fujii, S., et al. (1995). Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267, 1506-10.
118. Fang, W., Rivard, J. J., Ganser, J. A., Lebien, T. W., Nath, K. A., Mueller, D. L., and Behrens, T. W. (1995). Bcl-X(L) Rescues Wehi 231 B lymphocytes from oxidant-mediated death following diverse apoptotic stimuli. J. Immunol. 155, 66-75.
119. Sumantran, V. N., Ealovega, M. W., Nunez, G., Clarke, M. F., and Wicha, M. S. (1995). Overexpression of Bcl-XS sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res. 55, 2507-10.
120. Oltvai, Z. N., and Korsmeyer, S. J. (1994). Checkpoints of dueling dimers foil death wishes. Cell 79, 189-92.
121. Bump, N. J., Hackett, M., Hugunin, M., Seshagiri, S., Brady, K., Chen, P., Ferenz, C., Franklin, S., Ghayur, T., Li, P., Licari, P., Mankovich, J., Shi, L. F., Greenberg, A. H., Miller, L. K., and Wong, W. W. (1995). Inhibition Of Ice Family Proteases By Baculovirus Antiapoptotic Protein P35. Science 269, 1885-1888.
122. Xue, D., and Horvitz, H. R. (1995). Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein. Nature 377, 248-51.
123. Bertin, J., Mendrysa, S. M., Lacount, D. J., Gaur, S., Krebs, J. F., Armstrong, R. C., Tomaselli, K J., and Friesen, P. D. (1996). Apoptotic suppression by baculovirus P35 involves cleavage by and inhibition of a virus-induced Ced-3/Ice-like protease. J. Virol. 70, 6251-6259.
124. Komiyama, T., Ray, C., Pickup, D., Howard, A. D., Thornberry, N. A., Peterson, E. P., and Salvesen, G. (1994). Inhibition of ICE by the cowpox virus serpin Crma. J. Biol. Chem. 269, 19331-19337.
125. Tewari, M., Quan, L. T., Orourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S., and Dixit, V. M. (1995). Yama/Cpp32-Beta, a mammalian homolog of Ced-3, is a Crma-inhibitable protease that cleaves the death substrate poly(Adp-ribose) polymerase. Cell 81, 801-809.
126. Miura, M., Friedlander, R. M., and Yuan, J. Y. (1995). Tumor necrosis factor-induced apoptosis is mediated by a crma-sensitive cell death pathway. Proc. Natl. Acad. Sci. USA 92, 8318-8322.
127. Quan, L., Caputo, A., Bleackley, R., Pickup, D., and Salvesen, C. (1995). Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier. J. Biol. Chem. 270, 10377-10379.
128. Deveraux, Q. L., Takahashi, R., Salvesen, G. S., and Reed, J. C. (1997). X-linked lap is a direct inhibitor of cell-death proteases. Nature 388, 300-304.
129. Lazebnik, Y. A., Cole, S., Cooke, C. A., Nelson, W. G., and Earnshaw, W. C. (1993). Nuclear events of apoptosis in vitro in cell-free mitotic extracts: A model system for analysis of the active phase of apoptosis. J. Cell Biol. 123, 7-22.
130. Newmeyer, D. D., Farschon, D. M., and Reed, J. C. (1994). Cell-free apoptosis in Xenopus egg extracts: Inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell 79, 353-64.
131. Cosulich, S. C., Green, S., and Clarke, P. R. (1996). Bcl-2 regulates activation of apoptotic proteases in a cell-free system. Curr. Biol. 6, 997-1005.
132. Monney, L., Otter, I., Olivier, R., Ravn, U., Mirzasaleh, H., Fellay, I., Poirier, G. G., and Borner, C. (1996). Bcl-2 Overexpression blocks activation of the death protease Cpp32/Yama/ Apopain. Biochem. Biophys. Res. Commun. 221, 340-345.
133. Shimizu, S., Eguchi, Y., Kamiike, W., Matsuda, H., and Tsujimoto, Y. (1996). Bcl-2 expression prevents activation of the ice protease cascade. Oncogene 12, 2251-2257.
134. Reed, J. C. (1997). Double identity for proteins of the Bcl-2 family. Nature 387, 773-776.